5Cass I, Baldwin RL, Fasylova E,et al. Allelotype of papillary serous peritoneal carcinomas [J]. Gynecol Oncol,2001,82:69-76.
6Karlan BY, Baldwin RL, Lopez LE, et al. Peritoneal serous papillary carcinoma, a phenotypic variant of familial ovarian cancer:implications for ovarian cancer screening[J].Am J Obstet Gynecol, 1999,180:917-928.
7Halperin R, Zehavi S, Hadas E, et al. Immunohistochemical comparison of primary peritoneal and primary ovarian serous papillary carcinoma [J]. Int J Gynecol Pathol,2001,20:341-345.
8Bloss JD, Brady MF, Liao SY, et al. Extraovarian peritoneal serous papillary carcinoma:a phase Ⅱ trial of cisplatin and cyclophosphamide with comparison to a cohort with papillary serous ovarian carcinoma-a Gynecologic Oncology Group Study [J]. Gynecol Oncol, 2003,89:148 -154.
9Chiou SY ,Sheu MH ,Wang JH ,et al. Peritoneal serous papillary carcinoma: a reappraisal of CT imaging features and literature review [J]. Abdom Imaging, 2003,28 : 815-819.
10Piura B,Meirovitz M, Bartfeld M, et al. Peritoneal papillary serous carcinoma:study of 15 cases and comparison with stage Ⅲ-Ⅳ ovarian papillary serous carcinoma[J].J Surg Oncol, 1998,68 (3) : 173 -178.
3Eisenhauer EL,Sonoda Y, Levine DA, et al. Platinum resistance and impaired survival in patients with advanced primary peritoneal carcinoma: matched-case comparison with patients with epithelial ovarian carcinoma[J]. Am J Obstet Gynecol, 2008,198 (2) : 213. e1-213, e7.
